Thuy N Huynh, MD
Internal Medicine · Milpitas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 27
- 7 carriers
- Office
- 1
Offices
1 location
Looking this up.
Plans that list them
27 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Huynh’s office at (408) 262-9992 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
27 of 27 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$14,863
Medicare paid this office $14,863 for 28 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 23 | $4,168 | $82 |
| Long return visit (40+ min) | 11 | $2,795 | $127 |
| Short return visit (20+ min) | 14 | $1,708 | $71 |
| Influenza vaccine split virus, preservative free | 12 | $972 | $81 |
| Administration of influenza virus vaccine | 12 | $469 | $39 |
Who their Medicare patients are
28 Original Medicare patients in 2024. Average age 73 · Women 61% · Health risk score 0.60. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 64% · Diabetes 46%.
The office billed $36,860, Medicare allowed $21,506 and paid $14,863; for 170 services of 17 kinds; $2,359 of it was for drugs given in the office and $12,504 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 28 | 170 | 73 | 0.60 | $36,860 | $14,863 |
| 2023 | 32 | 129 | 73 | 0.71 | $27,145 | $9,407 |
| 2022 | 30 | 98 | 74 | 0.71 | $21,630 | $7,435 |
| 2021 | 29 | 95 | 74 | 0.66 | $18,500 | $7,055 |
| 2020 | 28 | 93 | 76 | 0.76 | $15,610 | $5,562 |
| 2019 | 36 | 176 | 76 | 0.81 | $25,835 | $10,766 |
| 2018 | 33 | 141 | 77 | 0.98 | $18,405 | $7,583 |
| 2017 | 38 | 149 | 76 | 1.08 | $17,900 | $7,160 |
| 2016 | 37 | 147 | 75 | 1.10 | $18,120 | $7,753 |
| 2015 | 44 | 201 | 75 | 1.07 | $27,345 | $12,656 |
| 2014 | 54 | 260 | 75 | 1.07 | $32,040 | $14,224 |
| 2013 | 56 | 289 | 75 | 1.09 | $31,140 | $13,120 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 25 | $4,699 | $87 |
| Short return visit (20+ min) | 16 | $1,641 | $66 |
| Influenza vaccine split virus, preservative free | 11 | $791 | $72 |
| Administration of influenza virus vaccine | 11 | $407 | $37 |
2022: 2 services
| Return visit (30+ min) | 25 | $3,548 | $83 |
| Long return visit (40+ min) | 13 | $1,607 | $107 |
2021: 1 service
| Return visit (30+ min) | 26 | $4,290 | $81 |
2020: 2 services
| Return visit (30+ min) | 20 | $3,091 | $72 |
| Long return visit (40+ min) | 14 | $930 | $58 |
2019: 5 services
| Return visit (30+ min) | 30 | $6,797 | $83 |
| Short return visit (20+ min) | 13 | $1,408 | $56 |
| Long return visit (40+ min) | 11 | $756 | $69 |
| Administration of influenza virus vaccine | 16 | $328 | $21 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 17 | $297 | $17 |
2018: 4 services
| Return visit (30+ min) | 27 | $3,679 | $75 |
| Short return visit (20+ min) | 22 | $2,270 | $52 |
| Administration of influenza virus vaccine | 15 | $386 | $26 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 16 | $280 | $17 |
2017: 4 services
| Return visit (30+ min) | 25 | $2,953 | $74 |
| Short return visit (20+ min) | 24 | $2,191 | $41 |
| Administration of influenza virus vaccine | 16 | $517 | $32 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 18 | $315 | $17 |
2016: 5 services
| Short return visit (20+ min) | 26 | $2,823 | $54 |
| Long return visit (40+ min) | 15 | $1,927 | $88 |
| Return visit (30+ min) | 21 | $1,828 | $73 |
| Administration of influenza virus vaccine | 18 | $542 | $30 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 18 | $315 | $17 |
2015: 5 services
| Long return visit (40+ min) | 27 | $4,591 | $112 |
| Return visit (30+ min) | 28 | $4,174 | $83 |
| Short return visit (20+ min) | 26 | $2,273 | $55 |
| Administration of influenza virus vaccine | 23 | $763 | $32 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 23 | $283 | $12 |
2014: 5 services
| Short return visit (20+ min) | 37 | $4,639 | $60 |
| Return visit (30+ min) | 31 | $4,125 | $72 |
| Long return visit (40+ min) | 18 | $2,822 | $105 |
| Administration of influenza virus vaccine | 27 | $902 | $31 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 27 | $342 | $12 |
2013: 5 services
| Short return visit (20+ min) | 45 | $5,737 | $51 |
| Return visit (30+ min) | 32 | $3,267 | $73 |
| Administration of influenza virus vaccine | 30 | $998 | $32 |
| Short return visit | 16 | $774 | $32 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 31 | $377 | $12 |
Drugs they prescribed that Part D paid
$92,297
Pharmacies billed $92,297 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
719 generic and 94 brand-name prescriptions · $92,297 in drug cost · 20 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 15 | $22,120 | $1,475 |
| Synjardy Xr | 24 | $21,667 | $903 |
| Rosuvastatin | 126 | $1,844 | $15 |
| Metformin Hcl Er | 75 | $840 | $11 |
| Valsartan | 32 | $812 | $25 |
See all 14 drugs
| Jardiance | 15 | $22,120 | $1,475 |
| Synjardy Xr | 24 | $21,667 | $903 |
| Rosuvastatin | 126 | $1,844 | $15 |
| Metformin Hcl Er | 75 | $840 | $11 |
| Valsartan | 32 | $812 | $25 |
| Atorvastatin | 52 | $600 | $12 |
| Amlodipine Besylate | 56 | $490 | $9 |
| Raloxifene | 11 | $464 | $42 |
| Losartan | 37 | $326 | $9 |
| Albuterol Sulfate Hfa | 12 | $296 | $25 |
| Montelukast | 12 | $221 | $18 |
| Lisinopril | 32 | $212 | $7 |
| Alendronate | 15 | $89 | $6 |
| Levothyroxine | 20 | $57 | $3 |
Year by year
| 2024 | 813 | 68 | None | 12% | $92,297 |
| 2023 | 539 | 50 | 0% (0) | None | $64,214 |
| 2022 | 455 | 47 | None | None | $37,410 |
| 2021 | 418 | 56 | None | 14% | $25,683 |
| 2020 | 437 | 36 | None | 9% | $15,907 |
| 2019 | 408 | 50 | None | 13% | $15,512 |
| 2018 | 437 | 50 | None | 16% | $16,961 |
| 2017 | 514 | 40 | None | 16% | $18,759 |
| 2016 | 615 | 50 | None | None | $27,388 |
| 2015 | 704 | 51 | None | None | $29,142 |
| 2014 | 864 | 59 | 1% (11) | None | $53,034 |
| 2013 | 1,112 | 77 | 1% (11) | None | $74,141 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Jardiance | 14 | $23,908 | $1,708 |
| Vascepa | 12 | $7,458 | $622 |
| Rosuvastatin | 86 | $1,978 | $23 |
| Metformin Hcl Er | 77 | $1,533 | $20 |
| Valsartan | 14 | $646 | $46 |
| Ezetimibe | 12 | $579 | $48 |
| Amlodipine Besylate | 50 | $574 | $11 |
| Losartan | 28 | $430 | $15 |
| Atorvastatin | 39 | $417 | $11 |
| Levothyroxine | 16 | $236 | $15 |
| Lisinopril | 24 | $193 | $8 |
2022: 8 drugs
| Rosuvastatin | 59 | $1,496 | $25 |
| Valsartan | 16 | $1,081 | $68 |
| Metformin Hcl Er | 52 | $889 | $17 |
| Amlodipine Besylate | 52 | $496 | $10 |
| Losartan | 30 | $382 | $13 |
| Atorvastatin | 47 | $343 | $7 |
| Levothyroxine | 19 | $186 | $10 |
| Metoprolol | 12 | $167 | $14 |
2021: 8 drugs
| Shingrix | 16 | $2,723 | $170 |
| Atorvastatin | 77 | $1,109 | $14 |
| Losartan | 42 | $694 | $17 |
| Amlodipine Besylate | 53 | $569 | $11 |
| Metformin Hcl Er | 35 | $543 | $16 |
| Rosuvastatin | 11 | $392 | $36 |
| Levothyroxine | 18 | $309 | $17 |
| Hydrochlorothiazide | 13 | $95 | $7 |
2020: 9 drugs
| Atorvastatin | 85 | $1,175 | $14 |
| Losartan | 45 | $688 | $15 |
| Metformin Hcl Er | 28 | $468 | $17 |
| Amlodipine Besylate | 60 | $413 | $7 |
| Levothyroxine | 18 | $383 | $21 |
| Metoprolol | 14 | $172 | $12 |
| Fluticasone Propionate | 11 | $154 | $14 |
| Omeprazole | 11 | $99 | $9 |
| Hydrochlorothiazide | 11 | $89 | $8 |
2019: 7 drugs
| Shingrix | 15 | $2,283 | $152 |
| Atorvastatin | 70 | $1,368 | $20 |
| Metoprolol | 17 | $619 | $36 |
| Losartan | 39 | $514 | $13 |
| Amlodipine Besylate | 50 | $501 | $10 |
| Metformin Hcl Er | 16 | $253 | $16 |
| Hydrochlorothiazide | 13 | $133 | $10 |
2018: 9 drugs
| Bystolic | 11 | $1,729 | $157 |
| Shingrix | 12 | $1,723 | $144 |
| Atorvastatin | 61 | $1,290 | $21 |
| Metoprolol | 24 | $817 | $34 |
| Valsartan | 14 | $667 | $48 |
| Levothyroxine | 22 | $522 | $24 |
| Losartan | 24 | $397 | $17 |
| Amlodipine Besylate | 59 | $378 | $6 |
| Metformin | 19 | $208 | $11 |
2017: 12 drugs
| Atorvastatin | 84 | $1,888 | $22 |
| Valsartan | 20 | $931 | $47 |
| Metoprolol | 24 | $931 | $39 |
| Levothyroxine | 33 | $760 | $23 |
| Losartan | 22 | $417 | $19 |
| Amlodipine Besylate | 54 | $403 | $7 |
| Montelukast | 14 | $255 | $18 |
| Atenolol | 12 | $149 | $12 |
| Hydrochlorothiazide | 12 | $106 | $9 |
| Alendronate | 14 | $82 | $6 |
| Metformin | 12 | $69 | $6 |
| Omeprazole | 11 | $61 | $6 |
2016: 14 drugs
| Atorvastatin | 94 | $2,209 | $23 |
| Valsartan | 27 | $1,370 | $51 |
| Metoprolol | 29 | $1,033 | $36 |
| Levothyroxine | 21 | $737 | $35 |
| Amlodipine Besylate | 55 | $439 | $8 |
| Losartan | 27 | $404 | $15 |
| Montelukast | 17 | $328 | $19 |
| Atenolol | 24 | $189 | $8 |
| Fluticasone Propionate | 17 | $170 | $10 |
| Clopidogrel | 11 | $138 | $13 |
| Simvastatin | 16 | $128 | $8 |
| Hydrochlorothiazide | 19 | $126 | $7 |
| Metformin | 11 | $94 | $9 |
| Alendronate | 16 | $62 | $4 |
2015: 15 drugs
| Valsartan | 24 | $2,379 | $99 |
| Atorvastatin | 85 | $2,009 | $24 |
| Edarbi | 13 | $1,873 | $144 |
| Levothyroxine | 29 | $868 | $30 |
| Metoprolol | 30 | $824 | $27 |
| Losartan | 30 | $626 | $21 |
| Montelukast | 35 | $559 | $16 |
| Amlodipine Besylate | 70 | $512 | $7 |
| Atenolol | 22 | $218 | $10 |
| Simvastatin | 17 | $193 | $11 |
| Fluticasone Propionate | 18 | $186 | $10 |
| Finasteride | 14 | $174 | $12 |
| Triamcinolone Acetonide | 11 | $127 | $12 |
| Hydrochlorothiazide | 17 | $70 | $4 |
| Carvedilol | 16 | $70 | $4 |
2014: 20 drugs
| Diovan | 24 | $10,384 | $433 |
| Atorvastatin | 68 | $1,930 | $28 |
| Metoprolol | 24 | $1,278 | $53 |
| Fenofibrate | 12 | $1,243 | $104 |
| Montelukast | 40 | $1,066 | $27 |
| Valsartan-Hydrochlorothiazide | 12 | $718 | $60 |
| Losartan | 57 | $686 | $12 |
| Amlodipine Besylate | 84 | $662 | $8 |
| Levothyroxine | 19 | $461 | $24 |
| Fluticasone Propionate | 24 | $429 | $18 |
| Triamcinolone Acetonide | 15 | $368 | $25 |
| Finasteride | 24 | $342 | $14 |
| Clopidogrel | 16 | $311 | $19 |
| Simvastatin | 27 | $252 | $9 |
| Atenolol | 40 | $213 | $5 |
| Allopurinol | 13 | $192 | $15 |
| Zolpidem | 20 | $164 | $8 |
| Omeprazole | 15 | $130 | $9 |
| Carvedilol | 11 | $128 | $12 |
| Hydrochlorothiazide | 14 | $84 | $6 |
2013: 25 drugs
| Diovan | 28 | $10,164 | $363 |
| Advair Diskus | 16 | $3,935 | $246 |
| Evista | 13 | $3,332 | $256 |
| Atorvastatin | 75 | $3,142 | $42 |
| Singulair | 13 | $2,509 | $193 |
| Montelukast | 37 | $1,577 | $43 |
| Metoprolol | 31 | $1,459 | $47 |
| Valsartan-Hydrochlorothiazide | 12 | $1,255 | $105 |
| Losartan | 75 | $1,148 | $15 |
| Amlodipine Besylate | 107 | $1,090 | $10 |
| Fluticasone Propionate | 42 | $1,067 | $25 |
| Nifedipine Er | 13 | $710 | $55 |
| Clopidogrel | 13 | $706 | $54 |
| Triamcinolone Acetonide | 13 | $562 | $43 |
| Simvastatin | 40 | $550 | $14 |
| Finasteride | 34 | $484 | $14 |
| Levothyroxine | 17 | $285 | $17 |
| Atenolol | 45 | $260 | $6 |
| Omeprazole | 26 | $259 | $10 |
| Lovastatin | 16 | $183 | $11 |
| Hydrochlorothiazide | 17 | $171 | $10 |
| Allopurinol | 18 | $133 | $7 |
| Clonidine | 13 | $100 | $8 |
| Zolpidem | 14 | $86 | $6 |
| Nortriptyline | 11 | $70 | $6 |
Money from drug and device companies
$542 in 2025
| 2025 | 3 | 14 | None | $542 |
| 2024 | 1 | 1 | None | $16 |
| 2022 | 1 | 2 | None | $176 |
| 2021 | 1 | 2 | None | $47 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $325 | 12 payments
|
| Lilly USA | Zepbound | $122 | 1 payment
|
| Merck Sharp & Dohme | Capvaxive | $95 | 1 payment
|
See all 14 published payments
| Novo Nordisk | Meals · 2025-10-29 | None | $15 |
| Novo Nordisk | Education · 2025-10-29 | None | $32 |
| Lilly USA | Meals · 2025-10-22 | Zepbound | $122 |
| Novo Nordisk | Meals · 2025-10-01 | Ozempic | $22 |
| Merck Sharp & Dohme | Meals · 2025-09-24 | Capvaxive | $95 |
| Novo Nordisk | Meals · 2025-09-02 | None | $17 |
| Novo Nordisk | Meals · 2025-08-27 | Ozempic | $13 |
| Novo Nordisk | Meals · 2025-07-30 | Ozempic | $28 |
| Novo Nordisk | Meals · 2025-07-07 | Rybelsus | $22 |
| Novo Nordisk | Meals · 2025-05-27 | Rybelsus | $23 |
| Novo Nordisk | Meals · 2025-05-15 | Ozempic | $91 |
| Novo Nordisk | Meals · 2025-04-17 | Ozempic | $17 |
| Novo Nordisk | Meals · 2025-02-03 | Rybelsus | $23 |
| Novo Nordisk | Meals · 2025-01-06 | Ozempic | $23 |
See earlier years (2024, 2022, 2021)
2024: $16
| Novo Nordisk | Rybelsus | $16 | 1 payment
|
2022: $176
| GlaxoSmithKline | Trelegy Ellipta | $176 | 2 payments
|
2021: $47
| Amarin Pharma | Vascepa | $47 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Novo Nordisk AS · Ozempic · 2022 | Their institution | $3,500 |
| Novo Nordisk AS · Ozempic · 2019 | Their institution | $3,455 |
| Novo Nordisk AS · Ozempic · 2021 | Their institution | $2,100 |
| Novo Nordisk AS · Ozempic · 2020 | Their institution | $1,365 |
Professional record
- NPI
- 1982711495
- Licence
- CA G073028
- Trained
- University of Kansas School of Med (Kc/Wich/Sal), 1990
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00G730281
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 1189 E Calaveras Blvd, Milpitas, CA, 95035
- NPI first listed
- 2006-08-23
- NPI last updated
- 2012-09-28
This is when the NPI record was last certified, not a medical board exam.